Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]

This article refers to:

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion

Tagami M, Sai R, Fukuda M, Azumi A. Clin Ophthalmol. 2017;11:403–408.

Page 405, Comparison of injection intervals section, line 6, “We also compared the intervals between the last and the second-to the-last intravitreal injection of ranibizumab and the first and the second intravitreal injection of aflibercept” should have read “We also compared the interval between the last injection of ranibizumab and the first injection of aflibercept with the interval between the first and the second injection of aflibercept”.